org placeholder image

Amber Van Laar

VP Clinical Development at Asklepios BioPharmaceutical

  • LinkedIn
map
ASKLEPIOS BIOPHARMACEUTICAL

ASKLEPIOS BIOPHARMACEUTICAL

  • description Description
    AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of transformative gene therapeutics, pion...

    Read More

  • Employees count Employees 501-1000
  • Revenue Revenue 10 Million to 25 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Asklepios BioPharmaceutical Org Chart and Mapping

Employees

Bethanne Bort

Vice President, Gmp Quality

Rachel Hedinger

Research Associate II (R&D Immunology)

Amita Pai

Research Associate III, Upstream Process Development

Chantal Letourneau

Vice President, Clinical Operations - Cns Gene Therapy

Douglas Snider

Director, Pathology and Histology

Frequently Asked Questions Regarding Amber Van Laar

Answer: Amber Van Laar works for Asklepios BioPharmaceutical as VP Clinical Development

Answer: Amber Van Laar’s role in Asklepios BioPharmaceutical is VP Clinical Development

Answer: Amber Van Laar's email address is v***@gmail.com

Answer: Amber Van Laar's business email address is v****@medstudent.pitt.edu

Answer: Amber Van Laar’s direct phone number is (***)-***-****

Answer: Amber Van Laar works in the industry of: Biotechnology

Answer: Amber Van Laar works Asklepios BioPharmaceutical located at 20 T.W. Alexander Dr Ste 110, Research Triangle Park, North Carolina, 27709, United States

Answer: Asklepios BioPharmaceutical's VP Clinical Development is Amber Van Laar

Answer: Amber Van Laar contact details:

  • Phone number  :  (***)-***-****
  • Email  :  v****@medstudent.pitt.edu

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access